OMTX-703

N/A

Report date: 2024/02/05 14:02:30

Base Information

Drug NameOMTX-703

Drug Alias NameOMTX003-TAM558 antibody drug conjugateOMTX-703

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Cleavable linker > VC linkerBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionTubulin polymerisation inhibitorsAnti-CD105

TargetsTubulinEndoglin

Therapy Area/IndicationsUveal melanomaPancreatic NeoplasmsSarcoma +[4]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesOncomatryx Biopharma Sl

China Registration ClassN/A

Develop Information

Active CompaniesOncomatryx Biopharma Sl

Inactive CompaniesN/A

Active IndicationsUveal melanomaPancreatic NeoplasmsSarcoma +[4]

Inactive IndicationsN/A

Other Information

ATC CodeN/A